Cellectis Ads Each Repr 1 Ord Spon盘中异动急速上涨5.48%

自选股智能写手05-10

北京时间2024年05月10日02时29分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价急速上涨5.48%。截至发稿，该股报3.27美元/股，成交量11.205万股，换手率0.16%，振幅6.77%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2434049613?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-10 02:29","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2434049613","market":"us","top_or_hot":-1,"title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.48%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月10日02时29分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价急速上涨5.48%。截至发稿，该股报3.27美元/股，成交量11.205万股，换手率0.16%，振幅6.77%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100229507926cdbd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.48%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.48%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-10 02:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100229507926cdbd&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月10日02时29分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价急速上涨5.48%。截至发稿，该股报3.27美元/股，成交量11.205万股，换手率0.16%，振幅6.77%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100229507926cdbd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLLS","symbol_name":"Cellectis S.A.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100229507926cdbd&s=b","article_id":"2434049613","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100229507926cdbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2434049613","pubTimestamp":1715279388,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月10日02时29分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速上涨5.48%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.01%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家专注于癌症免疫疗法开发的生物技术公司。消息层面，截至02时29分，Cellectis Ads Each Repr 1 Ord Spon股票正面舆情新闻比例75%。《Cellectis获得1.4亿美元战略投资，阿斯利康出手》资讯为影响Cellectis Ads Each Repr 1 Ord Spon的重要信息。Cellectis 表示该协议已获得员工代表、股东与法国经济部的支持。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CLLS":"Cellectis S.A.","BK4139":"生物科技"},"translate_title":"Cellectis Ads Each Repr 1 Ord Spon rose 5.48% in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLLS":0.9},"content_text":"北京时间2024年05月10日02时29分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价急速上涨5.48%。截至发稿，该股报3.27美元/股，成交量11.205万股，换手率0.16%，振幅6.77%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率-1.77倍。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Annovis Bio, Inc.、Seres Therapeutics, Inc.涨幅较大，Notable Labs, Ltd.、Allarity Therapeutics, Inc.、G1 Therapeutics, Inc.较为活跃，换手率分别为175.93%、173.47%、63.14%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Notable Labs, Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)，振幅分别为58.46%、57.24%、51.69%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家专注于癌症免疫疗法开发的生物技术公司。该公司参与基因编辑，试图引导人体免疫系统攻击癌细胞。Cellectis利用战略合作伙伴关系以及通过各种大学临床中心的合作。该公司的基因编辑技术允许从健康的捐赠者而不是患者自己身上创造健康的细胞。报告分为两部分:治疗学和植物学。它的治疗部门专注于新颖的癌症疗法，而它的植物部门专注于农业生物技术。消息层面，截至02时29分，Cellectis Ads Each Repr 1 Ord Spon股票正面舆情新闻比例75%。《Cellectis获得1.4亿美元战略投资，阿斯利康出手》资讯为影响Cellectis Ads Each Repr 1 Ord Spon的重要信息。该信息摘要如下：投资界消息，2024年5月6日，阿斯利康（AstraZeneca）宣布已完成向法国细胞基因疗法公司Cellectis1.4亿美元的投资，获得Cellectis公司44%的股份。该笔投资建立在2023年11月双方达成的初步协议基础上，当时阿斯利康承诺了1.05亿美元的投资，包括8000万美元的股权融资和2500万美元的预付款。Cellectis 表示该协议已获得员工代表、股东与法国经济部的支持。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2434049613"}

Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.48%

精彩评论

Cellectis Ads Each Repr 1 Ord Spon盘中异动急速上涨5.48%